Research Disclosures & Disclaimers

This website contains disclosures and disclaimers related to
published UBS Global Research products, including those related to
regulation, potential conflicts of interest as well as those provided
by third-party data providers describing limitations on use of their
products.

Alpek SAB de CV (ALPEKA.MX)*

UBS Rating and Price Target History Chart

Line chart explaining Price target vs Stock Price is described in below table

EQ Rating & Price Target Table

Date Stock Price (P) Price Target (P) Rating
2022-01-2423.9823.00Neutral
2022-03-1427.0028.00Neutral
2022-06-2326.1530.00Neutral
2022-08-0826.8031.00Neutral
2023-03-1022.3725.00Neutral
2023-06-0918.3521.00Neutral
2023-08-0917.4220.00Neutral
2023-11-0712.9915.00Neutral
2024-02-2910.9713.00Neutral
2024-06-2413.9214.00Neutral
2025-01-1313.5315.00Neutral
2025-03-3110.4413.00Neutral

Disclosures

  • Because this security exhibits higher-than-average volatility, the FSR has been set at 15% above the MRA for a Buy rating, and at -15% below the MRA for a Sell rating (compared with 6/-6% under the normal rating system).
Note : Historical Price Targets have been adjusted to account for any stock splits, rights issues and/or dividends which may have occurred for this security. Not Priced: Stock was not priced on the given date. No Rating: Issuer was not rated by UBS on the given day. No Price Target: For this issuer no Price Target was set by UBS on the given day. Issuers with an EQ Rating & Price Target Table are covered by UBS-IB Equity Research Analysts. Issuers without an EQ Rating & Price Target Table are not single stock covered.

* Issuers marked with an asterisk are covered by UBS-IB Equity Research Analysts. Issuers without an asterisk are not single stock covered.